Tesi focuses on investing into companies with revenue and a proven product-market-fit. They occasionally invest pre-revenue as well, for example into especially strong deep tech cases.

They’re not interested in pharmaceuticals, but other health tech is interesting.

They invest into companies that are based in Finland or have a strong connection with (interest in) Finland.

They prefer being co-lead or lead investor. They don’t invest solo.

Ticket size: €1,500k-€10,000k, maximum allocation with follow-on investments €15,000k per company